Navigation Links
Zeus Expands Class 7 Capabilities to Include the Processing of Advanced Polymers
Date:1/4/2011

ORANGEBURG, S.C., Jan. 4, 2011 /PRNewswire/ -- Zeus, Inc., a global leader in material science and high-performance polymer extrusions, announces it has expanded its capabilities and is now able to process Aeos® ePTFE and Electrospun Polymers in a new 5,000-sq-ft Class 7 manufacturing environment. This expansion allows for the processing of these advanced materials in a more controlled environment, resulting in compliance with stricter regulatory standards.

"Medical regulatory bodies are raising the bar on standards for devices in the industry and Zeus is committed to meeting this challenge," said Bob Jennings, Zeus Vice President, Sales and Marketing. "The processing of these advanced materials in a tightly controlled environment ensures that customer products meet the strictest regulatory requirements in the medical device industry."

Zeus is also equipped with a Class 7 Certified 5,000-sq-ft Biomaterials Facility dedicated exclusively to the extrusion, analysis, and characterization of bioabsorbable polymers and other advanced materials. Coupled with the state-of-the-art Biomaterials Facility, this latest Class 7 expansion further boosts Zeus' ability to provide its customers a speed-to-market pathway for their products. This brings Zeus' total Class 7 Certified manufacturing capabilities to 10,000 sq ft of controlled environment operating under ISO 13485 guidelines.

"Zeus is leading the charge in the marketplace by providing support from ideation all the way to polymer characterization for medical device companies," said Bob Ballard, Vice President, Research and Strategic Business Development. "In addition to our ability to process and extrude polymers in a Class 7 environment, we also have a dedicated analytical laboratory that allows us to provide real-time analysis and characterization of polymers while being manufactured."

About Zeus, Inc.:Zeus, Inc. is headquartered in Orangeburg, SC USA. Zeus is a world leader in material science and the production of high-performance polymer tubing used in demanding applications, operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling, aerospace, and mechanical markets. For more information, visit http://www.zeusinc.com.Press Contact:Samantha D. Farlow-MoydCommunications Coordinator (803) 268-9500publicrelations@zeusinc.comThis press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>

SOURCE Zeus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Crescent Healthcare Expands East Coast Presence
2. YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387
3. Hikma Expands its Global Injectables Business Through the Acquisition of Baxter Healthcare Corporations Multi-Source Injectables Business
4. Hikma Expands its Global Injectables Business - Live Webcast
5. Biostar Pharmaceuticals, Inc. Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500
6. HumanTouch Expands Services to the Centers for Disease Control and Prevention as a Prime Contract Holder as Part of $1.0 Billion Contract
7. Beta-Pro Expands Operations to Meet Demands for Human Cells in Hepatocyte Drug Discovery Market
8. iPierian Expands Leadership Team With Experienced Business Development and Intellectual Property Executives
9. Vital Therapies Expands SILVER Trial to Saudi Arabia
10. Launch of Two New Platforms for Microplate Analysis Expands Reader Portfolio and Ensures Molecular Devices Readers Meet all Combinations of Customer Needs
11. China BCT Further Expands its Footprint by Opening 12 New Retail Pharmaceutical Stores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofilerâ„¢ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and cooking events ... announced today. The bold new look is part of a transformation to increase ... a significant growth period. , It will also expand its service offering from its ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
Breaking Biology News(10 mins):